Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "RIL"

1436 News Found

ten23 health successfully tests West Synchrony S1 PFS system on fill-finish lines
News | May 04, 2026

ten23 health successfully tests West Synchrony S1 PFS system on fill-finish lines

Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners


Lilly posts explosive Q1 2026 results
News | May 04, 2026

Lilly posts explosive Q1 2026 results

Lifts full-year outlook as obesity drug boom accelerates


Sanofi India appoints Rahul Bhatnagar as Chairman of Board of Directors
People | May 03, 2026

Sanofi India appoints Rahul Bhatnagar as Chairman of Board of Directors

Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure


Thermo Fisher opens flagship US Bioprocess Design Center in Massachusetts
R&D | May 02, 2026

Thermo Fisher opens flagship US Bioprocess Design Center in Massachusetts

The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers


Indoco Remedies to exit ophthalmic business in strategic sale to Sunways India
News | May 02, 2026

Indoco Remedies to exit ophthalmic business in strategic sale to Sunways India

The transaction marks a clear portfolio reshuffle for Indoco


Inside India’s qPCR Transformation: Scale, Shift, and Structural Change
Opinion | May 01, 2026

Inside India’s qPCR Transformation: Scale, Shift, and Structural Change

Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine


Wanbury's Patalganga site clears Korea FDA inspection with zero observations
Drug Approval | April 30, 2026

Wanbury's Patalganga site clears Korea FDA inspection with zero observations

Patalganga plant received zero observation from USFDA earlier


Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout
News | April 30, 2026

Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout

The agreement could rise to $900 million if key commercial milestones are met


Illuminova ’26 showcases AI-driven future of medical education at SRM
Healthcare | April 29, 2026

Illuminova ’26 showcases AI-driven future of medical education at SRM

SRM Medical College Hospital and Research Centre hosts undergraduate research expo highlighting innovation, interdisciplinary collaboration, and the role of artificial intelligence


Rheumatology Awareness Walkathon 2026 spotlights arthritis and autoimmune care
Healthcare | April 28, 2026

Rheumatology Awareness Walkathon 2026 spotlights arthritis and autoimmune care

Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living